Myricetin Attenuated Diabetes-Associated Kidney Injuries and Dysfunction via Regulating Nuclear Factor (Erythroid Derived 2)-Like 2 and Nuclear Factor-κB Signaling.

MLA

Yang, Zi-Jun, et al. “Myricetin Attenuated Diabetes-Associated Kidney Injuries and Dysfunction via Regulating Nuclear Factor (Erythroid Derived 2)-Like 2 and Nuclear Factor-ΚB Signaling.” Frontiers in Pharmacology, vol. 10, June 2019, p. 647. EBSCOhost, https://doi.org/10.3389/fphar.2019.00647.

APA

Yang, Z.-J., Wang, H.-R., Wang, Y.-I., Zhai, Z.-H., Wang, L.-W., Li, L., Zhang, C., & Tang, L. (2019). Myricetin Attenuated Diabetes-Associated Kidney Injuries and Dysfunction via Regulating Nuclear Factor (Erythroid Derived 2)-Like 2 and Nuclear Factor-κB Signaling. Frontiers in Pharmacology, 10, 647. https://doi.org/10.3389/fphar.2019.00647

Chicago

Yang, Zi-Jun, Hong-Ru Wang, Yu-Iin Wang, Zi-Han Zhai, Liu-Wei Wang, Liang Li, Cheng Zhang, and Lin Tang. 2019. “Myricetin Attenuated Diabetes-Associated Kidney Injuries and Dysfunction via Regulating Nuclear Factor (Erythroid Derived 2)-Like 2 and Nuclear Factor-ΚB Signaling.” Frontiers in Pharmacology 10 (June): 647. doi:10.3389/fphar.2019.00647.